Assessment of Vitamin D Level as a Risk Factor and Illness Severity Indicator in COVID 19 Cases

Authors

  • Salma Mohamed Sabir Post graduate Student, Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University / UAE Author
  • May Khalil Ismail Associate professor, (Biochemistry), Department of Biomedical Sciences, College of Medicine, Gulf Medical University / UAE Author
  • Eman Hassan Ibrahim Assistant professor, (Pathology), Department of Biomedical Sciences, College of Medicine, Gulf Medical University / UAE Author
  • Zahra Arshad Khan Teaching Assistant, Department of Biomedical Sciences, College of Medicine, Gulf Medical University / UAE Author

Abstract

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-COV2) viruses using angiotensin converting enzyme 2 (ACE2) receptors, to enter human cells, these receptors are highly expressed in the lung alveolar cells, vascular endothelium, cardiac myocytes, and other cells. Inadequate vitamin D levels in the blood have been linked to a higher risk of COVID-19 severity. Objective: To determine the association between Vitamin D level and severity of COVID-19 infection. Materials and Method: A cross sectional study was conducted at Thumbay Hospital, Ajman, UAE. Enrolled 70 COVID-19 positive hospitalized patients with age group ≥ 18 years old of both genders. Patients taking vitamin D supplements were excluded from the study. The biochemical analysis for the collected blood samples was performed on the automated analyzer and assessed for significance analysis. Result: There is a statistically significant correlation between Vitamin D levels and disease severity (p < 0.05) as determined by Pearson’s Chi-square test. Independent t-test shown that there is a statistically significant difference with regards to gender, age groups, and co morbidity (p < 0.05). Pearson’s correlation revealed a moderate, positive correlation between Vitamin D levels and the severity of COVID-19 infection, which was statistically significant. Conclusion: Vitamin D levels affect COVID- 19 severity, with more severe cases showing vitamin D levels lower than normal when compared to severe cases with sufficient vitamin D levels. Furthermore, blood vitamin D levels are linked to age groups in COVID-19 patients. Vitamin D insufficiency and deficiency, on the other hand, was not linked to a higher risk of death prognosis, and co morbidities. 

Downloads

Download data is not yet available.

References

Al-Harbi S, Al-Harbi YA, Ezzat Abdellatif A, AlAhmadey ZZ, & Alahmadi S (2021) Retrospective

evaluation of the serum level of vitamin D among

COVID-19 patients in Al Madinah, Saudi Arabia.

Biotechnol Biochem Res 9 (1): 8-13. DOI:

https://doi.org/10.30918/BBR.91.21.018

Alipio M (2020) Vitamin D supplementation

could possibly improve clinical outcomes of

patients infected with coronavirus-2019

(COVID-19). SSRN Electronic Journal.

DOI: http://dx.doi.org/10.2139/ssrn.3571484

AlSafar H, Grant WB, Hijazi R, Uddin M,

Alkaabi N et al. (2021) COVID-19 disease

severity and death in relation to vitamin D

status among SARS-CoV-2-positive UAE

residents. Nutrients 13 (5): 1714. DOI:

https://doi.org/10.3390/nu13051714

Bassatne A, Basbous M, Chakhtoura M, El

Zein O, Rahme M et al. (2021) The link

between COVID-19 and VItamin D

(VIVID): A systematic review and metaanalysis. Metabolism 119: 154753. DOI:

https://doi.org/10.1016/j.metabol.2021.154753

Ben-Eltriki M, Hopefl R, Wright JM, & Deb S (2022)

Association between vitamin D status and risk of

developing severe COVID-19 infection: a metaanalysis of observational studies. Journal of the

American Nutrition Association 41 (7): 679-689.

DOI:https://doi.org/10.1080/07315724.2021.1951891

Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro

M, Formenti AM et al. (2020) Mechanisms in

endocrinology: vitamin D and COVID-19.

European journal of endocrinology 183 (5): R133-

R147. DOI: https://doi.org/10.1530/EJE-20-0665

Braun A, Chang D, Mahadevappa K, Gibbons FK, Liu

Y et al. (2011) Association of low serum 25-

hydroxyvitamin D levels and mortality in the

critically ill. Critical care medicine 39 (4): 671–677.

DOI:https://doi.org/10.1097/CCM.0b013e318206ccdf

Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S et

al. (2021) Vitamin D 25OH deficiency in COVID-

patients admitted to a tertiary referral hospital.

Clinical nutrition 40 (4): 2469-2472. DOI:

https://doi.org/10.1016/j.clnu.2020.10.055

Charoenngam N, Shirvani A, Reddy N, Vodopivec

DM, Apovian CM et al. (2021) Association of

vitamin D status with hospital morbidity and

mortality in adult hospitalized patients with

COVID-19. Endocrine Practice 27 (4): 271-278.

DOI: https://doi.org/10.1016/j.eprac.2021.02.013

Childs CE, Calder PC, & Miles EA (2019) Diet and

immune function. Nutrients 11 (8): 1933. DOI:

https://doi.org/10.3390/nu11081933

de Haan K, Groeneveld A, de Geus HR, Egal M, &

Struijs A (2014) Vitamin D deficiency as a risk

factor for infection, sepsis and mortality in the

critically ill: systematic review and metaanalysis. Critical care 18 (6): 1-8. DOI:

https://doi.org/10.1186/s13054-014-0660-4

De Smet D, De Smet K, Herroelen P, Gryspeerdt S,

& Martens GA (2021) Serum 25 (OH) D level

on hospital admission associated with COVID-

stage and mortality. American journal of

clinical pathology 155 (3): 381-388. DOI:

https://doi.org/10.1093/ajcp/aqaa252

Dong Y, Mo X, Hu Y, Qi X, Jiang F et al. (2020)

Epidemiology of COVID-19 among children in

China. Pediatrics 145 (6): e20200702. DOI:

https://doi.org/10.1542/peds.2020-0702

Emami A, Javanmardi F, Pirbonyeh N, & Akbari A

(2020) Prevalence of underlying diseases in

hospitalized patients with COVID-19: a

systematic review and meta-analysis. Archives of

academic emergency medicine 8 (1): e35. URL:

https://www.ncbi.nlm.nih.gov/pmc/articles/PM

C7096724

Escobar GJ, Adams AS, Liu VX, Soltesz L, Chen YFI et al. (2021) Racial disparities in COVID-19

testing and outcomes: retrospective cohort study

in an integrated health system. Annals of

internal medicine 174 (6): 786-793. DOI:

https://doi.org/10.7326/M20-6979

Ghelani D, Alesi S, & Mousa A (2021) Vitamin D and

COVID-19: An overview of recent evidence.

International Journal of Molecular Sciences 22 (19):

DOI: https://doi.org/10.3390/ijms221910559

Grant WB, Lahore H, McDonnell SL, Baggerly CA,

French CB et al. (2020) Evidence that vitamin D

supplementation could reduce risk of influenza and

COVID-19 infections and deaths. Nutrients 12 (4):

DOI: https://doi.org/10.3390/nu12040988

Greiller CL, & Martineau AR (2015) Modulation of

the immune response to respiratory viruses by

vitamin D. Nutrients 7 (6): 4240-4270. DOI:

https://doi.org/10.3390/nu7064240

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q et al.

(2020) Clinical characteristics of coronavirus

disease 2019 in China. New England Journal of

Medicine 382 (18): 1708-1720. DOI:

https://doi.org/10.1056/NEJMoa2002032

Hastie CE, Mackay DF, Ho F, Celis-Morales CA,

Katikireddi SV et al. (2020) Vitamin D

concentrations and COVID-19 infection in UK

Biobank. Diabetes & Metabolic Syndrome:

Clinical Research & Reviews 14 (4): 561-565.

DOI: https://doi.org/10.1016/j.dsx.2020.04.050

Infante M, Buoso A, Pieri M, Lupisella S, Nuccetelli M et

al. (2022) Low vitamin D status at admission as a risk

factor for poor survival in hospitalized patients with

COVID-19: an Italian retrospective study. Journal of

the American Nutrition Association 41 (3): 250-265.

DOI: https://doi.org/10.1080/07315724.2021.1877580

Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S

et al. (2020) Analysis of vitamin D level among

asymptomatic and critically ill COVID-19

patients and its correlation with inflammatory

markers. Scientific reports 10 (1): 20191. DOI:

https://doi.org/10.1038/s41598-020-77093-z

Katz J, Yue S, & Xue W (2021) Increased risk

for COVID-19 in patients with vitamin D

deficiency. Nutrition 84: 111106. DOI:

https://doi.org/10.1016/j.nut.2020.111106

Kazemi A, Mohammadi V, Aghababaee SK,

Golzarand M, Clark CC et al. (2021)

Association of vitamin D status with SARSCoV-2 infection or COVID-19 severity: a

systematic review and meta-analysis.

Advances in Nutrition 12 (5): 1636-1658. DOI:

https://doi.org/10.1093/advances/nmab012

Li Y, & Ding S (2020) Serum 25-Hydroxyvitamin D and

the risk of mortality in adult patients with Sepsis: A

meta-analysis. BMC infectious diseases 20 (1): 1-10.

DOI: https://doi.org/10.1186/s12879-020-4879-1

Liang JJ, Liu J, Chen Y, Ye B, Li N et al. (2020)

Characteristics of laboratory findings of COVID-19

patients with comorbid diabetes mellitus. Diabetes

research and clinical practice 167: 108351. DOI:

https://doi.org/10.1016/j.diabres.2020.108351

Mehra MR, Desai SS, Kuy S, Henry TD, & Patel

AN (2020) Cardiovascular disease, drug

therapy, and mortality in Covid-19. New

England Journal of Medicine 382 (25): e102.

DOI: https://do.org/10.1056/NEJMoa2007621

Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V et al.

(2020) Association of vitamin D status and other

clinical characteristics with COVID-19 test results.

JAMA network open 3 (9): e2019722. DOI:

https://doi.org/10.1001/jamanetworkopen.2020.19722

Murdaca G, Pioggia G, & Negrini S (2020) Vitamin

D and Covid-19: an update on evidence and

potential therapeutic implications. Clinical

and Molecular Allergy 18: 1-8. DOI:

https://doi.org/10.1186/s12948-020-00139-0

Parveen R, Sehar N, Bajpai R, & Agarwal NB (2020)

Association of diabetes and hypertension with

disease severity in covid-19 patients: A systematic

literature review and exploratory meta-analysis.

Diabetes research and clinical practice 166: 108295.

DOI: https://doi.org/10.1016/j.diabres.2020.108295

Raimondi F, Novelli L, Ghirardi A, Russo FM,

Pellegrini D et al. (2021) Covid-19 and gender:

lower rate but same mortality of severe disease

in women—an observational study. BMC

pulmonary medicine 21 (1): 1-11. DOI:

https://doi.org/10.1186/s12890-021-01455-0

Rhodes JM, Subramanian S, Laird E, Griffin G, &

Kenny RA (2021) Perspective: Vitamin D

deficiency and COVID‐19 severity–plausibly

linked by latitude, ethnicity, impacts on

cytokines, ACE2 and thrombosis. Journal of

internal medicine 289 (1): 97-115. DOI:

https://doi.org/10.1111/joim.13149

Sanyaolu A, Okorie C, Marinkovic A, Patidar R,

Younis K et al. (2020) Comorbidity and its

impact on patients with COVID-19. SN

comprehensive clinical medicine 2: 1069-1076.

DOI: https://doi.org/10.1007/s42399-020-00363-4

Somasundaram NP, Ranathunga I, Ratnasamy V,

Wijewickrama PSA, Dissanayake HA et al.

(2020) The impact of SARS-Cov-2 virus

infection on the endocrine system. Journal of the

Endocrine Society 4 (8): bvaa082. DOI:

https://doi.org/10.1210/jendso/bvaa082

Taha R, Abureesh S, Alghamdi S, Hassan RY,

Cheikh MM et al. (2021) The relationship

between vitamin D and infections including

COVID-19: any hopes? International journal

of general medicine: 3849-3870. URL:

https://www.tandfonline.com/doi/full/10.2147/I

JGM.S317421

Wang Z, Joshi A, Leopold K, Jackson S,

Christensen S et al. (2022) Association of

vitamin D deficiency with COVID‐19 infection

severity: Systematic review and meta‐analysis.

Clinical Endocrinology 96 (3): 281-287. DOI:

https://doi.org/10.1111/cen.14540

Zhang J, McCullough PA, & Tecson KM (2020)

Vitamin D deficiency in association with

endothelial dysfunction: Implications for

patients withCOVID-19. Reviews in

cardiovascular medicine 21 (3): 339-344. DOI:

https://doi.org/10.31083/j.rcm.2020.03.131

Downloads

Published

2022-04-30

Issue

Section

Articles

How to Cite

Mohamed Sabir, S., Khalil Ismail, M., Hassan Ibrahim, E., & Arshad Khan, Z. (2022). Assessment of Vitamin D Level as a Risk Factor and Illness Severity Indicator in COVID 19 Cases. History of Medicine, 8(2). http://13.200.237.241/HOM/index.php/medicine/article/view/386